Evidence map›Paper›PMID 35536527›Full record

ArticleMycopathologia2022

De novo Nanopore Genome Sequencing of the Clinical Diutina catenulata Type-strain CBS565.

Sander Boden, Florent Morio, Miaomiao Zhou, Bert Gerrits van den Ende, Ferry Hagen

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Mycopathologia, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 3 countries.

Sander BodenWesterdijk Fungal Biodiversity Institute, Uppsalalaan 8, 3584 CT, Utrecht, The Netherlands.ORCID http://orcid.org/0000-0002-9799-849X
Florent MorioNantes Université, CHU de Nantes, Cibles et Médicaments des Infections et de l'immunité, IICiMed, UR1155, 44000, Nantes, France.ORCID http://orcid.org/0000-0002-5859-6105
Miaomiao ZhouAvans University of Applied Sciences, Breda, The Netherlands.ORCID http://orcid.org/0000-0002-1387-8379
Bert Gerrits van den EndeWesterdijk Fungal Biodiversity Institute, Uppsalalaan 8, 3584 CT, Utrecht, The Netherlands.ORCID http://orcid.org/0000-0003-4439-3494
Ferry HagenWesterdijk Fungal Biodiversity Institute, Uppsalalaan 8, 3584 CT, Utrecht, The Netherlands. f.hagen@wi.knaw.nl.ORCID http://orcid.org/0000-0002-5622-1916
Avans University of Applied Sciences · NLCentre Hospitalier Universitaire de Nantes · FRHeidelberg University · DEWesterdijk Fungal Biodiversity Institute · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diutina catenulata is an ascomycetous yeast, that is regularly fluconazole-resistant and increasingly reported as the cause of invasive infection in humans. Here, we describe the de novo genome assembly of the clinical D. catenulata type-strain CBS565 and provide insights into the genome and compared it to an Illumina-sequenced environmental strain.

Indexed as

NanoporesSaccharomycetalesFluconazoleHigh-Throughput Nucleotide SequencingHumansSequence Analysis, DNAFluconazoleAntifungal resistantDiutina catenulataEmerging pathogenLong-read sequencingNanopore sequencing

Identifiers

PMID35536527
PMCPMC9325844
OpenAlexW4229458287

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.